- Investing Ideas
- Spanish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Spanish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.55
7D
-0.4%
1Y
10.2%
Pangaea Oncology
Market Cap: €55.7m
A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.
PANG
€1.55
7D
0%
1Y
-9.9%